SESSION TITLE: Outcomes in Lung Transplantation Slide
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Monday, October 24, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Development of donor specific antibodies (DSA) is common after lung transplantation (LT). It is considered a risk factor for bronchiolitis obliterans syndrome (BOS), a phenotype of chronic lung allograft dysfunction (CLAD). BOS is the major limitation for long term survival after LT. The aim of our study was to evaluate the association of prevalence and strength of DSA on survival and time to BOS.